Search

everythinglearnresearchcommunity

for

Search:↓

PRP therapy is a promising treatment for male hair loss on the vertex.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Neurokinin B levels are higher in the placentas of women with PCOS who have female babies.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

A new genetic mutation in the CAST gene may link PLACK syndrome to alopecia areata.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Minoxidil boosts hair growth by activating PGHS-1.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

The Kras mutation changes normal cell signals, leading to disrupted tissue structure and potential cancer.

Platelet-rich plasma therapy helps heal skin ulcers and stimulates hair growth in dermatology.

Finasteride may improve stem cell therapy for heart attacks by increasing cell survival.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

Upadacitinib improved multiple immune-related conditions in one patient.

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.

PRP combined with minoxidil may help treat hair loss, but better methods and standardized practices are needed.

C-reactive protein helps monocytes stick to blood vessel cells by causing oxidative stress.

Future treatments for hair loss may focus on personalized and regenerative approaches.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

Trypsin slows hair growth and affects color by causing cell death in hair follicles.

Neutrophils are key in causing chronic itch in atopic dermatitis, and blocking CXCR3 could reduce this itch.

Epiprofin helps cells grow in developing teeth, hair, and limbs.

A KRT32 gene variant causes loose anagen hair syndrome.